• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    ContextLogic Inc. - Class A Common Stock (NQ:LOGC)

    7.110 -0.010 (-0.14%)
    Streaming Delayed Price Updated: 12:01 PM EDT, Apr 29, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about ContextLogic Inc. - Class A Common Stock

    < Previous 1 2 3 Next >
    ContextLogic Slips Aftermarket On Q4 Earnings Miss: Retail’s Cautious
    Sentiment on Stocktwits ended ‘neutral’ on Wednesday compared to ‘bearish’ a day ago. 
    Via Stocktwits
    Earnings Scheduled For March 12, 2025
    Via Benzinga
    Looking Into LogicBio Therapeutics's Recent Short Interest
    LogicBio Therapeutics's (NASDAQ:LOGC) short percent of float has fallen 62.5% since its last report. The company recently reported that it has 29 thousand shares sold short, which is 0.12% of all... 
    Via Benzinga
    ContextLogic Stock Sees Retail Chatter Spike On BC Partners' Investment Ahead Of Q4 Results
    Under the deal, BC Partners planned to buy up to $150 million of convertible preferred units, a newly-formed Delaware limited liability company and a wholly-owned subsidiary of the company. 
    Via Stocktwits
    ContextLogic And BC Partners Forge $150 Million Strategic Partnership For Growth
    BC Partners invests $150M in ContextLogic, providing access to $300M in capital. New board members to maximize shareholder value and drive growth. 
    Via Benzinga
    LOGC Stock Earnings: ContextLogic Misses EPS, Beats Revenue for Q2 2024
    LOGC stock results show that ContextLogic missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    11 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Nasdaq Jumps 270 Points; Silver Surges Over 8%
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday. 
    Via Benzinga
    Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
    Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers 
    Via Benzinga
    Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
    Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share. 
    Via Benzinga
    S&P 500 Surges 2%; Crude Oil Rises Sharply
    U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday. 
    Via Benzinga
    GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
    Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week! 
    Via InvestorPlace
    Blue Apron (APRN) Stock Falls 33% on CFO Departure, Stock Sale
    Blue Apron (APRN) stock is sliding lower on Monday as investors react to its CFO leaving the company and plans for a stock sale. 
    Via InvestorPlace
    Why Is LogicBio (LOGC) Stock Up 600% Today?
    LogicBio (LOGC) stock is seeing massive gains on Monday following news that AstraZeneca (AZN) subsidiary Alexion is acquiring the company. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million. 
    Via Benzinga
    Why LogicBio Therapeutics Stock Is Soaring Today
    LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher Monday after the company announced it will be acquired by AstraZeneca PLC (NASDAQ: AZN) subsidiary Alexion for $2.07 per share.  
    Via Benzinga
    Why Are LogicBio Therapeutics Shares Skyrocketing Today?
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million. 
    Via Benzinga
    Gold Drops Over 1%; Viridian Therapeutics Shares Spike Higher
    U.S. stocks traded higher toward the end of trading, with the Dow Jones around 170 points on Monday. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
      
    Via Benzinga
    This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
    Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids. 
    Via Benzinga
    This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
    Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month. 
    Via Benzinga
    Dow Surges Over 100 Points; Crude Oil Falls Sharply
    U.S. stocks traded turned higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. 
    Via Benzinga
    Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
    Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New... 
    Via Benzinga
    Recap: LogicBio Therapeutics Q2 Earnings
      LogicBio Therapeutics (NASDAQ:LOGC) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
      
    Via Benzinga
    11 Health Care Stocks Moving In Monday's Pre-Market Session
      
    Via Benzinga
    LogicBio Therapeutics's Return On Capital Employed Overview
    According to data from Benzinga Pro, during Q1, LogicBio Therapeutics's (NASDAQ:LOGC) reported sales totaled $2.82 million. Despite a 26.49% increase in earnings, the company posted a loss of $6.66... 
    Via Benzinga
    Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
    Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. 
    Via Benzinga
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.